First trimester paroxetine use and the prevalence of congenital, specifically cardiac, defects: a meta-analysis of epidemiological studies.

Abstract

BACKGROUND Several studies have evaluated maternal first trimester paroxetine use and the prevalence of congenital defects, particularly cardiac defects. To synthesize current epidemiologic information, a meta-analysis was conducted. METHODS A systematic literature search was conducted for original research published from January 1, 1992, through… (More)
DOI: 10.1002/bdra.20627

Topics

Cite this paper

@article{Wurst2010FirstTP, title={First trimester paroxetine use and the prevalence of congenital, specifically cardiac, defects: a meta-analysis of epidemiological studies.}, author={Keele E. Wurst and Charles P. Poole and Sara A. Ephross and Andrew F. Olshan}, journal={Birth defects research. Part A, Clinical and molecular teratology}, year={2010}, volume={88 3}, pages={159-70} }